Literature DB >> 31685462

Influence of the α-Methoxy Group on the Reaction of Temocillin with Pseudomonas aeruginosa PBP3 and CTX-M-14 β-Lactamase.

Michael D Sacco1, Kyle G Kroeck1, M Trent Kemp1, Xiujun Zhang1, Logan D Andrews2, Yu Chen3.   

Abstract

The prevalence of multidrug-resistant Pseudomonas aeruginosa has led to the reexamination of older "forgotten" drugs, such as temocillin, for their ability to combat resistant microbes. Temocillin is the 6-α-methoxy analogue of ticarcillin, a carboxypenicillin with well-characterized antipseudomonal properties. The α-methoxy modification confers resistance to serine β-lactamases, yet temocillin is ineffective against P. aeruginosa growth. The origins of temocillin's inferior antibacterial properties against P. aeruginosa have remained relatively unexplored. Here, we analyze the reaction kinetics, protein stability, and binding conformations of temocillin and ticarcillin with penicillin-binding protein 3 (PBP3), an essential PBP in P. aeruginosa We show that the 6-α-methoxy group perturbs the stability of the PBP3 acyl-enzyme, which manifests in an elevated off-rate constant (k off) in biochemical assays comparing temocillin with ticarcillin. Complex crystal structures with PBP3 reveal similar binding modes of the two drugs but with important differences. Most notably, the 6-α-methoxy group disrupts a high-quality hydrogen bond with a conserved residue important for ligand binding while also being inserted into a crowded active site, possibly destabilizing the active site and enabling water molecule from bulk solvent to access and cleave the acyl-enzyme bond. This hypothesis is supported by the observation that the acyl-enzyme complex of temocillin has reduced thermal stability compared with ticarcillin. Furthermore, we explore temocillin's mechanism of β-lactamase inhibition with a high-resolution complex structure of CTX-M-14 class A serine β-lactamase. The results suggest that the α-methoxy group prevents hydrolysis by locking the compound into an unexpected conformation that impedes access of the catalytic water to the acyl-enzyme adduct.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  PBP3; Pseudomonas aeruginosazzm321990; beta-lactamases; beta-lactams; penicillin-binding proteins; temocillin; ticarcillin

Mesh:

Substances:

Year:  2019        PMID: 31685462      PMCID: PMC7187628          DOI: 10.1128/AAC.01473-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  66 in total

1.  Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.

Authors:  I Trehan; B M Beadle; B K Shoichet
Journal:  Biochemistry       Date:  2001-07-10       Impact factor: 3.162

2.  Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.

Authors:  Julien M Buyck; Sophie Guénard; Patrick Plésiat; Paul M Tulkens; Françoise Van Bambeke
Journal:  J Antimicrob Chemother       Date:  2012-01-03       Impact factor: 5.790

Review 3.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 4.  The spread of CTX-M-type extended-spectrum beta-lactamases.

Authors:  G M Rossolini; M M D'Andrea; C Mugnaioli
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

5.  Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.

Authors:  Mark J Mitton-Fry; Joel T Arcari; Matthew F Brown; Jeffrey M Casavant; Steven M Finegan; Mark E Flanagan; Hongying Gao; David M George; Brian S Gerstenberger; Seungil Han; Joel R Hardink; Thomas M Harris; Thuy Hoang; Michael D Huband; Rebecca Irvine; Manjinder S Lall; M Megan Lemmon; Chao Li; Jian Lin; Sandra P McCurdy; John P Mueller; Lisa Mullins; Mark Niosi; Mark C Noe; David Pattavina; Joseph Penzien; Mark S Plummer; Hud Risley; Brandon P Schuff; Veerabahu Shanmugasundaram; Jeremy T Starr; Jianmin Sun; Jennifer Winton; Jennifer A Young
Journal:  Bioorg Med Chem Lett       Date:  2012-07-20       Impact factor: 2.823

6.  Molecular replacement with MOLREP.

Authors:  Alexei Vagin; Alexei Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

7.  Interaction energies between beta-lactam antibiotics and E. coli penicillin-binding protein 5 by reversible thermal denaturation.

Authors:  B M Beadle; R A Nicholas; B K Shoichet
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

8.  Crystal structure of wild-type penicillin-binding protein 5 from Escherichia coli: implications for deacylation of the acyl-enzyme complex.

Authors:  Robert A Nicholas; Sandra Krings; Joshua Tomberg; George Nicola; Christopher Davies
Journal:  J Biol Chem       Date:  2003-10-10       Impact factor: 5.157

9.  CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea.

Authors:  Wonkeun Song; Hyukmin Lee; Kyungwon Lee; Seok Hoon Jeong; Il Kwon Bae; Jae-Seok Kim; Hyo-Sun Kwak
Journal:  J Med Microbiol       Date:  2009-02       Impact factor: 2.472

10.  CTX-M-15 is Established in Most Multidrug-Resistant Uropathogenic Enterobacteriaceae and Pseudomonaceae from Hospitals in Nigeria.

Authors:  David Olusoga Ogbolu; O A Terry Alli; Mark Alexander Webber; Adeolu Sunday Oluremi; Omoboriowo Moses Oloyede
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2018-03-07
View more
  2 in total

1.  Reduced In Vitro Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the pbp2x Gene Is Geographically Widespread.

Authors:  James M Musser; Stephen B Beres; Luchang Zhu; Randall J Olsen; Jaana Vuopio; Hanne-Leena Hyyryläinen; Kirsi Gröndahl-Yli-Hannuksela; Karl G Kristinsson; Jessica Darenberg; Birgitta Henriques-Normark; Steen Hoffmann; Dominque A Caugant; Andrew J Smith; Diane S J Lindsay; David M Boragine; Timothy Palzkill
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

2.  High-Throughput Crystallography Reveals Boron-Containing Inhibitors of a Penicillin-Binding Protein with Di- and Tricovalent Binding Modes.

Authors:  Hector Newman; Alen Krajnc; Dom Bellini; Charles J Eyermann; Grant A Boyle; Neil G Paterson; Katherine E McAuley; Robert Lesniak; Mukesh Gangar; Frank von Delft; Jürgen Brem; Kelly Chibale; Christopher J Schofield; Christopher G Dowson
Journal:  J Med Chem       Date:  2021-07-31       Impact factor: 8.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.